These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22005545)

  • 21. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol-3-kinase pathway.
    Reckamp KL
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S383-4. PubMed ID: 23160326
    [No Abstract]   [Full Text] [Related]  

  • 24. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
    Massarelli E; Papadimitrakopoulou VA
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S379-82. PubMed ID: 23160325
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on HER1-3 in advanced non-small-cell lung cancer.
    Horn L; Lovly C
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
    [No Abstract]   [Full Text] [Related]  

  • 26. New molecular targeted therapies integrated with radiation therapy in lung cancer.
    Provencio M; Sánchez A; Garrido P; Valcárcel F
    Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
    Somaiah N; Simon GR
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
    [No Abstract]   [Full Text] [Related]  

  • 28. Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).
    Reungwetwattana T; Weroha SJ; Molina JR
    Clin Lung Cancer; 2012 Jul; 13(4):252-66. PubMed ID: 22154278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in treatment of lung cancer with targeted therapy.
    Cagle PT; Chirieac LR
    Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation Therapy Oncology Group. Research Plan 2002-2006. Lung Cancer Committee.
    Bynhardt R; Komaki R; Ettinger D; Johnstone D; Bradley J; Franko A; Gaspar L; Gillin M; Langer C; Layne E; Movsas B; Munden R; Sause W; Stern J; Hsu J; Hartsell W; Yesner R;
    Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):44-52. PubMed ID: 11641014
    [No Abstract]   [Full Text] [Related]  

  • 31. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
    Weiss GJ
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
    [No Abstract]   [Full Text] [Related]  

  • 32. The Future of Molecular Medicine: Biomarkers, BATTLEs, and Big Data.
    Kim ES
    Am Soc Clin Oncol Educ Book; 2015; ():22-7. PubMed ID: 25993137
    [No Abstract]   [Full Text] [Related]  

  • 33. Special issue: Current vision on target enzymes for cancer therapy.
    Bishayee A; Kamal MA
    Semin Cancer Biol; 2019 Jun; 56():iii-v. PubMed ID: 30503852
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer.
    Zhang I; Zaorsky NG; Palmer JD; Mehra R; Lu B
    Lancet Oncol; 2015 Oct; 16(13):e510-21. PubMed ID: 26433824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
    Ataman OU; Sambrook SJ; Wilks C; Lloyd A; Taylor AE; Wedge SR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e447-54. PubMed ID: 22819210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalized lung cancer treatment based on molecular determinants.
    Simon GR
    J S C Med Assoc; 2011 Oct; 107(5):183-4. PubMed ID: 22057801
    [No Abstract]   [Full Text] [Related]  

  • 37. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances highlighted at US cancer meeting.
    McCarthy M
    Lancet; 2002 May; 359(9320):1835. PubMed ID: 12044383
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers.
    Singh N; Krishnakumar S; Kanwar RK; Cheung CH; Kanwar JR
    Drug Discov Today; 2015 May; 20(5):578-87. PubMed ID: 25433305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemoradiotherapy Using Molecular Targeted Therapy].
    Akamatsu H
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):416-418. PubMed ID: 29650895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.